These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 7125430)

  • 21. [Comparative effects of probucol and placebo on blood cholesterol in patients on long-term treatment (author's transl)].
    Mc Caughan D
    Nouv Presse Med; 1980 Oct; 9(40):3018-20. PubMed ID: 7443444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Experimental pharmacology of probucol (author's transl)].
    Choisy H; Millart H
    Nouv Presse Med; 1980 Oct; 9(40):2981-4. PubMed ID: 7443435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of the erythrocyte calcium-sensitive potassium channel by probucol.
    Howland JL; Daughtey JN; Donatelli M; Theofrastous JP
    Pharmacol Res Commun; 1984 Nov; 16(11):1057-64. PubMed ID: 6097921
    [No Abstract]   [Full Text] [Related]  

  • 24. [Probucol: mechanism of action (author's transl)].
    Infante R
    Nouv Presse Med; 1980 Oct; 9(40):2976-80. PubMed ID: 7443434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacology of probucol. II].
    Donatelli L
    Clin Ter; 1984 Mar; 108(6):475-95. PubMed ID: 6233067
    [No Abstract]   [Full Text] [Related]  

  • 26. Probucol-lipid pharmacology.
    Kritchevsky D
    Artery; 1982; 10(1):1-6. PubMed ID: 6807261
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacology and toxicology of probucol.
    Marshall FN
    Artery; 1982; 10(1):7-21. PubMed ID: 7046693
    [No Abstract]   [Full Text] [Related]  

  • 28. Antioxidant activity of probucol. Short communication.
    Minakami H; Sotomatsu A; Ohma C; Nakano M
    Arzneimittelforschung; 1989 Sep; 39(9):1090-1. PubMed ID: 2590258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dieldrin-14C elimination from chickens.
    Davison KL; Sell JL
    Arch Environ Contam Toxicol; 1978; 7(3):369-77. PubMed ID: 727832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of cholestyramine and chenodesoxycholic acid on liver cirrhosis. An experimental study in rats].
    de Heer K; Werner B; Sauer HD; Klöppel G
    Z Exp Chir; 1980 Apr; 13(2):105-13. PubMed ID: 7445625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The effects of probucol in man (author's transl)].
    Leutenegger M
    Nouv Presse Med; 1980 Oct; 9(40):2985-9. PubMed ID: 7443436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Probucol: effects on the metabolism of low density and high density lipoproteins in moderate hypercholesterolaemia.
    Magill P; Whiting C; Hammett F; Glick I; Miller NE; Lewis B
    Artery; 1982; 10(2):88-94. PubMed ID: 7092581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pharmacology of probucol. I].
    Donatelli L
    Clin Ter; 1984 Mar; 108(5):367-88. PubMed ID: 6232074
    [No Abstract]   [Full Text] [Related]  

  • 34. [New derivatives of clofibrate and probucol. Preliminary study of their hypolipemic activity].
    de Meglio P; Ravenna F; Manzardo S; Gentili P; Riva M
    Farmaco Sci; 1985 Nov; 40(11):833-44. PubMed ID: 4085644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diet and probucol in lowering cholesterol concentrations. Additive effects on plasma cholesterol concentrations in patients with familial type ii hyperlipoproteinemia.
    LeLorier J; DuBreuil-Quidoz S; Lussier-Cacan S; Huang YS; Davignon J
    Arch Intern Med; 1977 Oct; 137(10):1429-34. PubMed ID: 335998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Probucol reduces the rate of association of apolipoprotein C-III with dimyristoylphosphatidylcholine.
    McLean LR; Hagaman KA
    Biochim Biophys Acta; 1988 Apr; 959(3):201-5. PubMed ID: 3355846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of probucol on lipoprotein protein kinetics.
    Nestel PJ
    Artery; 1982; 10(2):95-8. PubMed ID: 7092582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of oxidized lipoproteins in the pathogenesis of atherosclerosis.
    Kita T; Yokode M; Ishii K; Kume N; Nagano Y; Arai H; Otani H; Ueda Y; Hara S
    Clin Exp Pharmacol Physiol Suppl; 1992; 20():37-42. PubMed ID: 1446408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of probucol on the cholesterol content of skin in type II hyperlipoproteinemias.
    Beaumont JL; Jacotot B; Buxtorf JC; Silvestre M; Beaumont V
    Artery; 1982; 10(1):71-87. PubMed ID: 7092577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of a human microvascular endothelial cell line as a model system to evaluate cholesterol uptake.
    Pruckler JM; Lawley TJ; Ades EW
    Pathobiology; 1993; 61(5-6):283-7. PubMed ID: 8297494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.